India  

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months

Video Credit: Cover Video STUDIO - Duration: 01:00s - Published
Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months

Pfizer and BioNTech announced that their ongoing Phase 3 clinical vaccine trial confirms protection for at least six months after the second dose.


You Might Like


💡 newsR Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical corporation

Covid jab ‘super Saturday’ as London stadiums transformed into giant clinics [Video]

Covid jab ‘super Saturday’ as London stadiums transformed into giant clinics

Thousands of Covid-19 jabs are being administered after stadiums and football grounds in London were transformed into mass vaccination centres. Giant jab clinics have been set up at the Olympic Stadium, Stamford Bridge, Tottenham Hotspur FC, Charlton Athletic FC, Selhurst Park and Crystal Palace Athletics Centre. Chelsea FC had 6,000 Pfizer vaccines to administer on Saturday, with the jab being offered to all adults over the age of 18 yet to receive a first dose, as well as those awaiting a second Pfizer dose. The “super pop-ups” are expected to attract thousands of young Londoners on “super Saturday” who are now eligible to receive their first Covid jab.

Credit: PA - Press Association STUDIO    Duration: 01:00Published
Palestinians cancel vaccines deal with Israel over expiry dates [Video]

Palestinians cancel vaccines deal with Israel over expiry dates

The Palestinian Authority has cancelled a deal with Israel to receive about one million Pfizer-BioNTech vaccines saying the doses are about to expire.

Credit: Euronews English    Duration: 01:15Published
CDC Says Cases of Heart Inflammation After 2nd COVID Shot Higher Than Expected, but Rare [Video]

CDC Says Cases of Heart Inflammation After 2nd COVID Shot Higher Than Expected, but Rare

On Thursday, the Centers for Disease Control and Prevention said that there have been a higher-than-expected number of cases of heart inflammation in 16- to 24-year-olds after receiving their second dose of Pfizer’s or Moderna’s COVID-19 vaccines.

Credit: Cover Video STUDIO    Duration: 01:21Published
U.S. will be 'arsenal of vaccines' for the world -Biden [Video]

U.S. will be 'arsenal of vaccines' for the world -Biden

U.S. President Joe Biden said on Thursday that a donation of 500 million doses of the Pfizer COVID-19 vaccine to the world's poorest countries would supercharge the battle with the virus and comes with "no strings attached." This report produced by Yahaira Jacquez.

Credit: Reuters - Politics    Duration: 02:16Published

BioNTech BioNTech German biotechnology company

Pfizer/BioNTech Covid-19 vaccine approved for use in 12 to 15-year-olds [Video]

Pfizer/BioNTech Covid-19 vaccine approved for use in 12 to 15-year-olds

The UK has approved the Pfizer/BioNTech coronavirus vaccine for use in children aged 12 to 15.The Medicines and Healthcare products Regulatory Agency (MHRA) authorised the use of the jab in the younger age group on Friday following a review of its safety, quality and effectiveness.The Pfizer Covid-19 jab was the first to be authorised for use in the UK at the end of last year.

Credit: PA - Press Association STUDIO    Duration: 01:00Published
Moderna files for full U.S. approval of COVID-19 vaccine [Video]

Moderna files for full U.S. approval of COVID-19 vaccine

Moderna on Tuesday filed for full U.S. approval of its COVID-19 vaccine, becoming the second drugmaker to do so after Pfizer and its German partner BioNTech sought full clearance for their vaccine last month. This report produced by Freddie Joyner.

Credit: Reuters - Politics    Duration: 01:04Published
Scientist reveals how she celebrated successful vaccine trials [Video]

Scientist reveals how she celebrated successful vaccine trials

CNN’s Chris Cuomo speaks to Katalin Karikó, a senior vice president at BioNTech whose research in mRNA technology helped pave the way for the coronavirus vaccine.

Credit: Bleacher Report AOL    Duration: 03:58Published

Related news from verified sources

Protection from its vaccine still strong 6 months on: Moderna

Moderna Inc said on Tuesday that its Covid-19 vaccine still showed strong protection against the...
IndiaTimes - Published


Related videos from verified sources

EU to vaccinate 70% of adults by July, two months ahead of schedule, says Von der Leyen [Video]

EU to vaccinate 70% of adults by July, two months ahead of schedule, says Von der Leyen

The European Commission president has announced that 70% of the adult population in the EU will receive at least one vaccine dose by July.

Credit: Euronews English     Duration: 01:33Published
Moderna, Pfizer COVID Vaccines Don’t Pose Serious Risk During Pregnancy, Study Says [Video]

Moderna, Pfizer COVID Vaccines Don’t Pose Serious Risk During Pregnancy, Study Says

WBZ TV's Breana Pitts reports.

Credit: WBZ CBS Boston     Duration: 00:16Published
First Dose Pfizer Vaccine Available At FEMA-Supported Sites [Video]

First Dose Pfizer Vaccine Available At FEMA-Supported Sites

Vaccine available to those 16 and up.

Credit: CBS4 Miami     Duration: 00:35Published